Stock GODAVARI6 GODAVARI DRUGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Godavari Drugs Limited

Equities

GODAVARI6

INE362C01012

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:56 2024-05-21 EDT 		5-day change 1st Jan Change
97.2 INR -0.66% Intraday chart for Godavari Drugs Limited +2.53% +7.93%
02-13 Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
02-13 Godavari Drugs Limited Appoints Dinesh Udpa as Non-Executive-Independent Director CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 238 175.8 86.98 344.5 492.5 570.4
Enterprise Value (EV) 1 403.6 381.1 348.7 632.7 700.5 898
P/E ratio 28.7 x 14.6 x 4.34 x 8.35 x 9.38 x 15.1 x
Yield - - - - - -
Capitalization / Revenue 0.37 x 0.21 x 0.09 x 0.28 x 0.31 x 0.36 x
EV / Revenue 0.63 x 0.46 x 0.36 x 0.52 x 0.43 x 0.56 x
EV / EBITDA 9.94 x 6.94 x 5.58 x 6.43 x 6.12 x 7.33 x
EV / FCF -17.6 x -11.3 x -5.76 x -16.2 x 10.6 x -7.55 x
FCF Yield -5.68% -8.87% -17.4% -6.17% 9.43% -13.2%
Price to Book 1.4 x 0.96 x 0.43 x 1.41 x 1.66 x 1.71 x
Nbr of stocks (in thousands) 7,531 7,531 7,531 7,531 7,531 7,531
Reference price 2 31.60 23.35 11.55 45.75 65.40 75.74
Announcement Date 18-08-07 19-08-11 20-07-24 21-07-22 22-04-25 23-07-21
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 644.5 835.4 959.1 1,227 1,613 1,600
EBITDA 1 40.62 54.89 62.47 98.4 114.5 122.5
EBIT 1 30.77 44.02 50.84 86.17 97.49 103.1
Operating Margin 4.77% 5.27% 5.3% 7.02% 6.05% 6.44%
Earnings before Tax (EBT) 1 13.14 17.46 22.89 57.06 70.21 49.35
Net income 1 8.294 12.08 20.01 41.28 52.45 37.86
Net margin 1.29% 1.45% 2.09% 3.37% 3.25% 2.37%
EPS 2 1.100 1.600 2.660 5.480 6.970 5.030
Free Cash Flow 1 -22.94 -33.82 -60.57 -39.01 66.08 -118.9
FCF margin -3.56% -4.05% -6.32% -3.18% 4.1% -7.43%
FCF Conversion (EBITDA) - - - - 57.74% -
FCF Conversion (Net income) - - - - 125.99% -
Dividend per Share - - - - - -
Announcement Date 18-08-07 19-08-11 20-07-24 21-07-22 22-04-25 23-07-21
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 166 205 262 288 208 328
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 4.078 x 3.74 x 4.19 x 2.929 x 1.817 x 2.674 x
Free Cash Flow 1 -22.9 -33.8 -60.6 -39 66.1 -119
ROE (net income / shareholders' equity) 4.99% 6.85% 10.4% 18.5% 19.4% 12%
ROA (Net income/ Total Assets) 3.25% 4% 4.03% 6.15% 6.33% 5.78%
Assets 1 255.5 302.4 496.3 670.9 828.8 654.8
Book Value Per Share 2 22.60 24.20 26.90 32.40 39.30 44.40
Cash Flow per Share 2 2.150 2.030 1.890 2.180 3.020 4.100
Capex 1 36.2 25.8 68.9 16.7 52.5 93
Capex / Sales 5.62% 3.09% 7.18% 1.36% 3.25% 5.81%
Announcement Date 18-08-07 19-08-11 20-07-24 21-07-22 22-04-25 23-07-21
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
GODAVARI DRUGS LIMITED Stock Godavari Drugs Limited
+7.93% 8.85M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+22.35% 44.12B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+22.22% 22.61B
SANDOZ GROUP AG Stock Sandoz Group AG
+17.81% 15.11B
CIPLA LIMITED Stock Cipla Limited
+15.73% 13.61B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+57.91% 13.34B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.98% 6.94B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+15.65% 5.75B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GODAVARI6 Stock
  4. Financials Godavari Drugs Limited
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW